The landscape of dementia diagnosis has progressed radically with the arrival of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-based checks that could detect Alzheimer's pathology many years right before signs or symptoms emerge. Though these technological improvements represent amazing progress in being familiar with neurodegenerative conditions, https://mild-cognitive-impairment12110.snack-blog.com/38200315/the-enduring-worth-of-cognitive-assessment-for-more-mature-grownups